§ BIOTECHNOLOGY
USD · BiotechnologyAUTL
AUTOLUS THERAPEUTICS PLC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
39 increased/new, 22 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 33.6M | 6.8% | +12% |
| Syncona Portfolio Ltd | 16.6M | 89.3% | ±0% |
| ARMISTICE CAPITAL, LLC | 15.8M | 0.4% | −10% |
| Tetragon Partners GP Ltd | 9.5M | 2.5% | ±0% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 9.5M | 0.0% | ±0% |
| Frazier Life Sciences Management, L.P. | 4.4M | 0.2% | −4% |
◇ AC INTELLIGENCE
Top institutional owners for AUTL as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER49.3% · 0 holders
OTHER42.8% · 60 holders
QUALITY / COMPOUNDER3.6% · 1 holder
DEALER / BANK2.0% · 11 holders
SYSTEMATIC / QUANT0.9% · 3 holders
TACTICAL / MACRO0.7% · 4 holders
PASSIVE / INDEX0.6% · 5 holders
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AUTL in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention AUTL yet.